Audentes Therapeutics Inc (BOLD)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO, CA 94108

Audentes Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the development and commercialization of gene therapy treatments for people with serious rare diseases. Audentes Therapeutics serves customers in the United States.

View SEC Filings from BOLD instead.

View recent insider trading info

Funds Holding BOLD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BOLD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP IV LLC

  • 10% Owner
25,913,539 2020-03-23 0

MORRISON SCOTT W

  • Director
0 2020-03-19 1

SQUINTO STEPHEN P

  • Director
  • 10% Owner
0 2020-03-12 0

WOIWODE THOMAS

  • Director
  • 10% Owner
4,959,769 2020-03-03 0

SILVERSTEIN JONATHAN

  • Director
  • 10% Owner
0 2020-02-27 0

JARRETT JENNIFER

0 2020-02-12 1

LANGE LOUIS G

  • Director
0 2020-01-15 4

HOLLES NATALIE C. PRESIDENT AND COO

  • Officer
0 2020-01-15 5

SOLOWAY THOMAS P EXECUTIVE VICE PRESIDENT, CFO

  • Officer
0 2020-01-15 6

SCHUETZ THOMAS J.

  • Director
0 2020-01-15 1

PATTERSON MATTHEW R CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-01-15 7

SMITH JULIE

  • Director
0 2020-01-15 1

GOLDBERG MARK ALAN

  • Director
0 2020-01-15 1

MOSBROOKER ERIC SVP, CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-01-15 2

MELTZ MARK A SVP, GENERAL COUNSEL

  • Officer
0 2020-01-15 2

CONNER EDWARD R. SVP, CHIEF MEDICAL OFFICER

  • Officer
0 2020-01-15 4

PARMAR KUSH

  • Director
1,775 2019-09-24 0

5AM VENTURES III, L.P.

5AM PARTNERS III, LLC

5AM CO-INVESTORS III, L.P.

DIEKMAN JOHN D

ROCKLAGE SCOTT M

SCHWAB ANDREW J.

  • 10% Owner
3,316,059 2019-09-16 0

ORBIMED ADVISORS LLC

  • 10% Owner
0 2019-09-12 0

PRASAD SUYASH SENIOR VP & CHIEF MED OFFICER

  • Officer
17,479 2019-06-05 2

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
498,219 2019-03-11 0

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURES IV, LLC

  • 10% Owner
5,174,727 2019-01-14 0

NEWMAN MARY SVP, REGULATORY AFFAIRS

  • Officer
660 2018-11-15 0

GRAY JOHN T. SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
0 2018-09-28 0

NAGLER DAVID SVP, HR & CORP. AFFAIRS

  • Officer
0 2018-06-20 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP IV LLC

ISALY SAMUEL D

  • 10% Owner
1,868,966 2017-11-20 0

5AM PARTNERS III, LLC

  • 10% Owner
4,714,262 2016-07-25 0

VERSANT VENTURES IV, LLC

  • 10% Owner
No longer subject to file 2016-07-25 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments